Dianthus Therapeutics Inc... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PAMC | 52.16 | 0.62 | +1.20% |
| Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC) | |||
| IAT | 57.17 | -0.05 | -0.09% |
| iShares U.S. Regional Banks ETF (IAT) | |||
| KBWB | 87.05 | -0.18 | -0.21% |
| Invesco KBW Bank ETF (KBWB) | |||
| XCNY | 33.43 | -0.17 | -0.51% |
| State Street SPDR S&P Emerging Markets ex-China ETF (XCNY) | |||
| SNDQ | 10.11 | -0.54 | -5.07% |
| Tradr 2X Short SNDK Daily ETF (SNDQ) | |||
A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with EDIT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then EDIT could also see price increases.
| Ticker / NAME | Correlation To DNTH | 1D Price Change % | ||
|---|---|---|---|---|
| DNTH | 100% | +0.31% | ||
| EDIT - DNTH | 46% Loosely correlated | -1.95% | ||
| XENE - DNTH | 44% Loosely correlated | +4.68% | ||
| IMTX - DNTH | 42% Loosely correlated | -3.87% | ||
| ORKA - DNTH | 42% Loosely correlated | +0.16% | ||
| REPL - DNTH | 41% Loosely correlated | +1.59% | ||
More | ||||
The Aroon Indicator for DNTH entered a downward trend on October 01, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 187 similar instances where the Aroon Indicator formed such a pattern. In 171 of the 187 cases the stock moved lower. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DNTH as a result. In 80 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
DNTH moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for DNTH crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DNTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where DNTH advanced for three days, in 240 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
DNTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. DNTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.191) is normal, around the industry mean (26.780). P/E Ratio (3.238) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. DNTH's P/S Ratio (2500.000) is slightly higher than the industry average of (438.009).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.